Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
Date:8/3/2009

SAN DIEGO, Aug. 3, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the second quarter ended June 30, 2009.

Arena reported a lower net loss allocable to common stockholders in the second quarter of 2009 of $38.0 million, or $0.48 per share, compared to a net loss allocable to common stockholders in the second quarter of 2008 of $65.8 million, or $0.89 per share, and a net loss allocable to common stockholders in the first half of 2009 of $88.6 million, or $1.16 per share, compared to a net loss allocable to common stockholders in the first half of 2008 of $120.8 million, or $1.64 per share.

"We are on track to announce results from the BLOSSOM trial in September, which we expect will be the final piece of lorcaserin's NDA that we plan to submit by the end of this year," stated Jack Lief, Arena's President and Chief Executive Officer. "Based on its emerging efficacy, safety and tolerability profile, lorcaserin has the potential to be an important new treatment option for patients needing to better manage their weight and improve their overall health. Our improved financial position strengthens our ability to obtain marketing approval for lorcaserin and our position in partnership discussions."

As expected, research and development expenses declined significantly to $24.2 million in the second quarter of 2009 from $56.2 million in the second quarter of 2008. Research and development expenses declined to $66.8 million in the first half of 2009 from $103.6 million in the first half of 2008. This decrease primarily resulted from decreased clinical trial costs due to the completion of clinical and preclinical studies as Arena prioritized its spending towards activities that support filing a New Drug Ap
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Arena Pharmaceuticals Announces Public Offering of Common Stock
3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
9. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
10. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... (PRWEB) September 21, 2014 According to latest ... the highest birth rate since 1966 (10.5 births per 1,000 ... their early 40s has risen steadily by 2 percent per ... births to women aged 50 and over) also rose, the ... there were more than nine times as many first births ...
(Date:9/20/2014)... 2014 Recently, iFitDress.com, a well-known wedding dress ... beautiful party dresses . In addition, the company has launched ... of the promotion is to benefit all of its big ... online store now. , Along with beautiful party dresses, ... It has recently released its new sexy short prom outfits ...
(Date:9/20/2014)... NV (PRWEB) September 21, 2014 ... Dr. Kenneth Pullman that is helping thousands of people ... diabetes symptoms without shots, pills, or prescriptions has caught ... , “There are currently tens of millions of ... Type 1 and Type 2 diabetes, and unfortunately, big ...
(Date:9/20/2014)... Vegas, NV (PRWEB) September 21, 2014 ... method created by fitness expert Craig Ballantyne that is showing ... their metabolism and blast away stubborn body fat using simple ... attention of Shane Michaels, prompting an investigative review. , ... isn’t always calories in vs. calories out for all people,” ...
(Date:9/20/2014)... Los Cabos, Baja, Mexico (PRWEB) September 20, 2014 ... Los Cabos properties, including Villa del Palmar Cabo San ... minimal damages in relation to Hurricane Odile, with plans ... beginning of October. , As of Sept. 19, all ... properties have returned home, thanks to a coordinated effort ...
Breaking Medicine News(10 mins):Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2
... 12 Having funded $2 million,total to support 27 ... year of its Rapid Response Innovation Awards,(RRIA) initiative, The ... $2 million to a second round of funding in ... good ideas without delay.,Under this program the Foundation accepts ...
... 12, 2007) A new study confirms that chronic ... cardiovascular events in diabetic patients with damage to the ... anti-diabetic drug pioglitazone may help to lower this risk, ... Nephrology. , "The data confirm that chronic kidney disease ...
... Government Officials Will Explain Regulatory Plans for Cutting-Edge,Technology at ... Dec. 12 Nanotechnology was,incorporated into more than $50 ... By 2014, the market will grow to $2.6 trillion.,By ... will be,sold -- up from more than $3 billion ...
... Dermatologist Doing His Part to Warn Consumers, OMAHA, ... has been in the news for the past several ... Fig, the,parent company for up to 18 facilities around ... procedure, has closed its stores and is,considering declaring bankruptcy. ...
... Mattel Children,s Hospital UCLA,interacting with more than 100 Children ... ... NEW YORK, Dec. 12 Vapps, Inc., the ... today,will premiere their inaugural "Vapps, Holiday Storybook" event, featuring,multi-platinum ...
... depressive disorder (MDD) is the most common major mental ... 75% of people who recover from an episode of ... majority having multiple recurrences. MDD is the leading ... functional impairment, morbidity, and mortality. Few studies have assessed ...
Cached Medicine News:Health News:Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response 2Health News:Pioglitazone lowers cardiovascular risk in diabetic patients with kidney disease 2Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 4Health News:Will Lipodissolve Continue to Remain Popular? 2Health News:Ashlee Simpson to Read Holiday Stories to Children in Hospitals Throughout the Country Premiering 'Vapps' Holiday Storybook' Event 2Health News:Venlafaxine extended-release effective for patients with major depression 2
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Pressure ... today announced it has received and approved all ... HT48 instruments and has begun to manufacture the ... first instrument will be ready for shipment by ... built and released at a rate of about ...
(Date:9/19/2014)... 19, 2014  Over 200 runners participated in the ... the Radiation Oncology Institute (ROI), hosted by Radiation Business ... Park in San Francisco.  "Donations are ... of Radiation Business Solutions, "but at this point, ... $70,000 for the ROI this year. This surpasses last ...
(Date:9/19/2014)... PHILADELPHIA , Sept. 19, 2014  PCI ... Services International (Biotec).  Biotec is a leading provider ... Services headquartered in Bridgend, Wales ... .  The addition significantly expands PCI,s presence in ... medicinal products by adding packaging, storage and distribution ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
... ,Forest Laboratories, Inc. (NYSE: FRX ) and ... a phase II clinical trial of,cariprazine (RGH-188), an ... bipolar I disorder. For the primary endpoint,the Young ... patients with,acute manic episodes treated with cariprazine experienced ...
... Phase II Data Continue to Highlight Potential of NeoVista,s ... Epiretinal ... 18-month data from the company,s Phase II feasibility study,examining its novel ... (AMD) at the 41st Scientific Meeting of,the Retina Society. The long-term ...
Cached Medicine Technology:Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 2Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 3Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 4Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 5NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4
Double-ended. Designated most popular model or size....
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size....
2 mm tip....
Octagonal handle. 3 mm wide....
Medicine Products: